In this study, a prognostic risk-scoring model for NSCLC was established based on prognostic LRGs that were significantly differentially expressed between NSCLC and control groups (VIPR1, NEK2, HMGA1, FERMT1, SLC7A5, and TNS4). This evidence concerns the gene VIPR1 and non-small cell lung carcinoma.